Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · September 05, 2017

Efficacy and Safety of SSRIs and SNRIs for Psychiatric Disorders Among Children and Adolescents

JAMA Psychiatry

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Psychiatry
Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-Analysis
JAMA Psychiatry 2017 Aug 30;[EPub Ahead of Print], C Locher, H Koechlin, SR Zion, C Werner, DS Pine, I Kirsch, RC Kessler, J Kossowsky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading